Vanda Pharmaceuticals Inc.
MELATONIN AGONIST TREATMENT
Last updated:
Abstract:
Melatonin Agonist, MA-1, is administered at effective doses.
Status:
Application
Type:
Utility
Filling date:
1 Sep 2020
Issue date:
24 Dec 2020